| Financial Year |
March 31 2023 |
| Monetary Funds |
2,843,405,014.31 |
| Held-for-trading Financial Assets |
381,487.68 |
| Notes Receivable |
375,007.75 |
| Accounts Receivable |
1,001,735,084.91 |
| Advances to Suppliers |
23,707,814.35 |
| Other Receivables |
5,677,256.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,219,239,609.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,655,178,063.36 |
| Total Current Assets |
12,641,893,209.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,846,671.37 |
| Fixed Assetes |
4,264,057,409.86 |
| Under-construction Projects |
213,056,223.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,001,693.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
80,275,792.56 |
| Other Non-Current Assets |
107,367,330.53 |
| Sub-Total of Non-Current Assets |
5,168,757,274.68 |
| Total Assets |
17,810,650,484.15 |
| Short-Term Loans |
1,145,951,936.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
942,671,246.53 |
| Accounts Payable |
2,727,732,568.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,805,436.13 |
| Taxes Payable |
62,917,423.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
92,019,913.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,148,233.23 |
| Other Current Liabilities |
3,799,851.46 |
| Sub-Total of Current Liabilities |
5,129,080,525.08 |
| Long-term Loans |
352,569,722.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
79,131,583.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
748,631,089.34 |
| Total Liabilities |
5,877,711,614.42 |
| Paid-In Capital(Or Share Stock) |
800,000,000.00 |
| Capital Surplus |
5,225,071,831.84 |
| Surplus Reserve |
1,138,698,338.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,749,679,291.00 |
| Minority Stockholder's Interest |
600,072.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,932,338,797.19 |
| Owner's Equity（Stockholder's Equity） |
11,932,938,869.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,810,650,484.15 |
